Dr. Suzanne L. Kirby, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of North Carolina at Chapel Hill School of Medicine (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 283
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: University of North Carolina at Chapel Hill School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
NC license 34371
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Duke University Hospital Durham, NC
- Novant Health New Hanover Regional Medical Center Wilmington, NC
- Duke Regional Hospital Durham, NC
Medical groups
- Duke Health Integrated Practice, Inc (3,185 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 283
- Services billed
- 1,236
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 168 | 108 |
| Established patient office or other outpatient visit, 30-39 minutes | 164 | 115 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 130 | 46 |
| New patient office or other outpatient visit, 60-74 minutes | 37 | 37 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 27 | 27 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Brukinsa (zanubrutinib) | 171 |
| Lenalidomide | 132 |
| Revlimid (lenalidomide) | 125 |
| Acyclovir Other prescribers in Cary, NC | 105 |
| Jakafi (ruxolitinib phosphate) | 83 |
| Ninlaro (ixazomib citrate) | 63 |
| Pomalyst (pomalidomide) | 42 |
| Imatinib Mesylate | 39 |
| Pantoprazole Sodium Other prescribers in Cary, NC | 37 |
| Gabapentin Other prescribers in Cary, NC | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 3 payments worth $208 in total to this clinician.
| Servier Pharmaceuticals LLC | $146 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $43.25 |
| Celgene Corporation | $18.67 |
| Food and Beverage | $164 |
|---|---|
| Education | $43.25 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 25, 2025 | Education ENHERTU · Oncology · in-kind Company’s descriptionJournal Article | $43.25 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.